Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …

Triple-negative breast cancer (TNBC) is associated with an increased risk of early
recurrence and distant metastasis, as well as the development of therapeutic resistance and …

MicroRNA (miRNA) represents a promising class of therapeutic nucleic acid drugs, while
delivery challenges remain that impede the advancement of miRNA therapy, largely …

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that
displays highly aggressive with poor prognosis. Owing to the limited targets and drugs for …

Highlights•TNBC is an unmet medical need with poor survival rates and no targeted
therapy.•TNBC resists conventional chemotherapy and surgical strategies.•A review of 121 …

Breast cancer (BCa) is the leading cause of women's death worldwide; among them, triple‐
negative breast cancer (TNBC) is one of the most troublesome subtypes with easy …

Abstract Aims Deregulation of microRNA (miRNA) function has been linked to numerous
human cancers, such as Triple Negative Breast Cancer (TNBC). Exosomes, a subgroup of …

Background Triple negative breast cancer (TNBC) is an aggressive disease, but recent
studies have identified heterogeneity in patient outcomes. However, the utility of histologic …

Background: Several available data suggest the association between specific molecular
subtypes and BRCA1/2 mutational status. Previous investigations showed the association …

Abstracts The phenomenal rise in cancer over the past few years has made it the second
leading cause of death worldwide. Breast cancer constitutes the predominant cancer …